- Home
- SNSE vs AMBO Comparison
SNSE vs AMBO Comparison
Compare SNSE & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- AMBO
- Stock Information
- Founded
- SNSE 2005
- AMBO 2000
- Country
- SNSE United States
- AMBO United States
- Employees
- SNSE N/A
- AMBO N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- SNSE Health Care
- AMBO Real Estate
- Exchange
- SNSE Nasdaq
- AMBO Nasdaq
- Market Cap
- SNSE 11.2M
- AMBO 11.3M
- IPO Year
- SNSE 2021
- AMBO 2010
- Fundamental
- Price
- SNSE $11.13
- AMBO $3.54
- Analyst Decision
- SNSE Strong Buy
- AMBO
- Analyst Count
- SNSE 4
- AMBO 0
- Target Price
- SNSE $72.50
- AMBO N/A
- AVG Volume (30 Days)
- SNSE 3.5K
- AMBO 18.5K
- Earning Date
- SNSE 11-13-2025
- AMBO 08-05-2025
- Dividend Yield
- SNSE N/A
- AMBO N/A
- EPS Growth
- SNSE N/A
- AMBO N/A
- EPS
- SNSE N/A
- AMBO 0.69
- Revenue
- SNSE N/A
- AMBO $9,699,000.00
- Revenue This Year
- SNSE N/A
- AMBO N/A
- Revenue Next Year
- SNSE N/A
- AMBO N/A
- P/E Ratio
- SNSE N/A
- AMBO $5.01
- Revenue Growth
- SNSE N/A
- AMBO 23.73
- 52 Week Low
- SNSE $5.00
- AMBO $1.17
- 52 Week High
- SNSE $17.40
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- SNSE 71.14
- AMBO 49.30
- Support Level
- SNSE $9.35
- AMBO $3.47
- Resistance Level
- SNSE $10.00
- AMBO $3.67
- Average True Range (ATR)
- SNSE 0.51
- AMBO 0.22
- MACD
- SNSE 0.09
- AMBO -0.04
- Stochastic Oscillator
- SNSE 94.27
- AMBO 37.27
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.